This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Ludwig-Maximilians-Universitat München, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 50 
2 out of 1,335 
Years Active: 2018-2019
Title: **Martin H. Groschup: Pioneering Innovations in Neurodegenerative Disease Treatment**
Introduction
Martin H. Groschup is a prominent inventor based in Munich, Germany, known for his innovative contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With two patents to his name, Groschup's work focuses on addressing critical health challenges linked to protein aggregation.
Latest Patents
Groschup's latest patent revolves around a drug designed for inhibiting the aggregation of proteins that are involved in diseases associated with neurodegenerative conditions. The invention presents a compound represented by formula (E), which can be utilized for both the treatment and prevention of diseases prompted by protein aggregation. Furthermore, the patent details pharmaceutical and diagnostic compositions that incorporate this compound, as well as a comprehensive kit for its application. The innovation also includes a method for imaging protein aggregation deposits, which is crucial for early diagnosis and treatment monitoring.
Career Highlights
Groschup has made significant strides in his career, having been associated with reputable research institutions. He has worked with the Max Planck Society for the Advancement of Science and Ludwig Maximilian University of Munich, where his contributions to scientific research have been invaluable. His work reflects a commitment to advancing our understanding and treatment of complex diseases.
Collaborations
Throughout his career, Groschup has collaborated with distinguished colleagues, including Armin Giese and Uwe Bertsch. These partnerships have further enriched his research endeavors and facilitated a multidisciplinary approach to tackling the challenges posed by neurodegenerative diseases.
Conclusion
In summary, Martin H. Groschup exemplifies the spirit of innovation in the realm of drug development for neurodegenerative diseases. Through his patents and impactful collaborations, he continues to contribute significantly to the scientific community, striving to improve the lives of those affected by these debilitating conditions. His work illustrates the potential that innovative thinking holds in addressing some of the most pressing health issues of our time.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile